Bottom line
What is DHEAX's expense ratio?
DHEAX's expense ratio is 0.82%, or about $82 a year on every $10,000 invested. That is more expensive than 82% of short-term bond funds we track (median 0.47%). Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Oct 28, 2026
DHEAX fee table
| Net expense ratio | 0.82% |
|---|---|
| Gross expense ratio | 0.82% |
| Management fee | 0.35% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.22% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Oct 28, 2026
What DHEAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DHEAX | $433 | $505 | $694 | $1,238 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.82% expense ratio costs roughly $46,100 in lost growth, versus about $27,300 for the median short-term bond fund (0.47%).